ArticleHemaSphere2026

A functional prognostic model predicts progression-free survival in patients with relapsed chronic lymphocytic leukemia treated with ibrutinib + venetoclax.

Johanne U Hermansen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.